David Devon

David Devos, Doctor of Neurology, Doctor of Neuroscience and Professor in Medical Pharmacology CHU, University of Lille, INSERM U1172). He is heading the resarch team in Neurosciences DVCD U1172. His main domain of research concerns development of innovative therapeutic strategies in neurodegenerative diseases from the concept through in vitro and in vivo research to large phase IIb clinical trials. He published more than 280 articles (New England J Medicine, Nat Med, Lancet Neurol, Brain…), H-index > 63, obtained several awards: Nominated for the Price of European innovation Award, Price of European stars Award, the stars of the North of France, European Pharmacology Scientific Award, University Foundation, I-SITE-ULNE, ILAB, DeepTech Price, Recherche Hospitalo-Universitaire…, obtained 6 patents leading to 2 industrial transfers for which he cofounded 2 Start up being spin off of the research team, participated in > 35 studies including 14 multicenter trials and 14 as Coordinator, 4 European Commission funded projects (H2020) in neurosciences & European clinical trial. Career competitive research funding > 20M€. He is consultant and running research at the expert center of Parkinson’s disease (PD) and Amyotrophic Lateral Sclerosis (ALS) of Lille. He is co-coordinating the French network of PD (NS-Park-F-CRIN) and of ALS (ACT4ALS-MND).